open access

Vol 48, No 2 (2014)
Original research articles
Submitted: 2013-08-08
Get Citation

Secondary prevention of stroke in elderly people in Poland—Results of PolSenior study

Beata Łabuz-Roszak, Michał Skrzypek, Krystyna Pierzchała, Agnieszka Machowska-Majchrzak, Małgorzata Mossakowska, Jerzy Chudek, Iwona Mańka-Gaca, Wojciech Bartman, Andrzej Więcek
DOI: 10.1016/j.pjnns.2013.11.001
·
Neurol Neurochir Pol 2014;48(2):85-90.

open access

Vol 48, No 2 (2014)
Original research articles
Submitted: 2013-08-08

Abstract

Background and purpose

The purpose of the study was to evaluate the frequency of use of oral antiplatelet (OAP) and anticoagulant (OAC) drugs as secondary stroke prevention among older people in Poland and its association with sociodemographic factors, place of residence, and concomitant cardiovascular risk factors.

Material and methods

The study group consisted of 426 subjects with a history of a previous stroke (mean age of 81.5±8.2 years), participants of multicentre, population-based PolSenior study.

Results

Among the study group, 261 people (61.3%) used at least one drug as a secondary prevention. OAPs were regularly used by 237 people (55.6%), and OACs—by 25 people (5.9%). The most often used drug was acetylsalicylic acid. Ticlopidine was more frequently used than clopidogrel, and acenocoumarol was used more often than warfarin. Among all of the concomitant cardiovascular risk factors, congestive heart failure was mostly associated with OAP treatment, and a history of atrial fibrillation—with OAC treatment. Use of drugs did not depend on age, sex, place of residence (rural or urban), level of education and personal income, but it was associated with the region where the respondents lived.

Conclusions

Secondary cardiovascular preventive therapy in Poland is used too rarely in older people after stroke, and it especially concerns anticoagulant therapy in those with a history of atrial fibrillation. Structured educational programmes should be developed in Poland to improve usage of secondary preventive therapy in the elderly.

Abstract

Background and purpose

The purpose of the study was to evaluate the frequency of use of oral antiplatelet (OAP) and anticoagulant (OAC) drugs as secondary stroke prevention among older people in Poland and its association with sociodemographic factors, place of residence, and concomitant cardiovascular risk factors.

Material and methods

The study group consisted of 426 subjects with a history of a previous stroke (mean age of 81.5±8.2 years), participants of multicentre, population-based PolSenior study.

Results

Among the study group, 261 people (61.3%) used at least one drug as a secondary prevention. OAPs were regularly used by 237 people (55.6%), and OACs—by 25 people (5.9%). The most often used drug was acetylsalicylic acid. Ticlopidine was more frequently used than clopidogrel, and acenocoumarol was used more often than warfarin. Among all of the concomitant cardiovascular risk factors, congestive heart failure was mostly associated with OAP treatment, and a history of atrial fibrillation—with OAC treatment. Use of drugs did not depend on age, sex, place of residence (rural or urban), level of education and personal income, but it was associated with the region where the respondents lived.

Conclusions

Secondary cardiovascular preventive therapy in Poland is used too rarely in older people after stroke, and it especially concerns anticoagulant therapy in those with a history of atrial fibrillation. Structured educational programmes should be developed in Poland to improve usage of secondary preventive therapy in the elderly.

Get Citation

Keywords

Stroke, The elderly, Secondary prevention, Oral anticoagulant drugs, Antiplatelet drugs, Acetylsalicylic acid

About this article
Title

Secondary prevention of stroke in elderly people in Poland—Results of PolSenior study

Journal

Neurologia i Neurochirurgia Polska

Issue

Vol 48, No 2 (2014)

Pages

85-90

DOI

10.1016/j.pjnns.2013.11.001

Bibliographic record

Neurol Neurochir Pol 2014;48(2):85-90.

Keywords

Stroke
The elderly
Secondary prevention
Oral anticoagulant drugs
Antiplatelet drugs
Acetylsalicylic acid

Authors

Beata Łabuz-Roszak
Michał Skrzypek
Krystyna Pierzchała
Agnieszka Machowska-Majchrzak
Małgorzata Mossakowska
Jerzy Chudek
Iwona Mańka-Gaca
Wojciech Bartman
Andrzej Więcek

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk, Poland
tel.:+48 58 320 94 94, fax:+48 58 320 94 60, e-mail: viamedica@viamedica.pl